caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1194921551

Sara CrossMD

Infectious DiseaseMemphis, TNI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
38
Unique beneficiaries
—
Total services
64
Distinct HCPCS
2
Medicare payment
$5K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 117 Infectious Disease providers in TN — bottom quintile (cohort median 558).
REFERRAL NETWORK

Where Sara Cross's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 4 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SHELBY COUNTY HEALTH CARE CORPORATION60230
WEBER, KARL21211
Geoffrey Goodin
Diagnostic Radiology · Memphis, TN
14114
BREWER, SUSAN11169
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
SHELBY COUNTY HEALTH CARE CORPORATION26142
Laura Sprabery
Internal Medicine · Memphis, TN
1825
Laboratory Corporation Of America Holdings
Clinical Laboratory · Birmingham, AL
1748
John Norwood
Internal Medicine · Jonesboro, AR
11417
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
444
Beneficiaries
—
Total drug cost
$714K
Distinct drugs
22
Brand share
50.7%
Top prescribed drugs
Darunavir/Cob/Emtri/Tenof Alaf43 claims
Amlodipine Besylate40 claims
Abacavir/Dolutegravir/Lamivudi37 claims
Atorvastatin Calcium35 claims
Bictegrav/Emtricit/Tenofov Ala34 claims
QUALITY · MIPS · 2024
Final MIPS score
81.0
Quality
64.6
Cost
77.3
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.25%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.